PF00299804, an Irreversible Pan-ERBB Inhibitor, Is...

Cancer Research 2007 / 12 Vol. 67; Iss. 24

PF00299804, an Irreversible Pan-ERBB Inhibitor, Is Effective in Lung Cancer Models with EGFR and ERBB2 Mutations that Are Resistant to Gefitinib

Engelman, J. A., Zejnullahu, K., Gale, C.-M., Lifshits, E., Gonzales, A. J., Shimamura, T., Zhao, F., Vincent, P. W., Naumov, G. N., Bradner, J. E., Althaus, I. W., Gandhi, L., Shapiro, G. I., Nelson,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
67
Language:
english
Journal:
Cancer Research
DOI:
10.1158/0008-5472.CAN-07-1885
Date:
December, 2007
File:
PDF, 415 KB
english, 2007
Conversion to is in progress
Conversion to is failed